نتایج جستجو برای: brain metastases

تعداد نتایج: 520732  

2017
Vaios Hatzoglou Jamie Tisnado Alpesh Mehta Kyung K Peck Mariza Daras Antonio M Omuro Kathryn Beal Andrei I Holodny

Brain metastases originating from different primary sites overlap in appearance and are difficult to differentiate with conventional MRI. Dynamic contrast-enhanced (DCE)-MRI can assess tumor microvasculature and has demonstrated utility in characterizing primary brain tumors. Our aim was to evaluate the performance of plasma volume (Vp) and volume transfer coefficient (Ktrans ) derived from DCE...

Journal: :Neurologic clinics 2003
Teri D Nguyen Lisa M DeAngelis

Brain metastases are a common complication of cancer and alter patient management more than metastases at any other site of distant progression. Supportive therapies include steroids and antiseizure medications. Definitive treatments include radiation therapy, surgery, and chemotherapy. The optimal choice of treatment and overall prognosis largely depend on patient characteristics and the exten...

2014
Dirk Rades Stefan Huttenlocher Dagmar Hornung Oliver Blanck Steven E Schild Dorothea Fischer

BACKGROUND An important issue in palliative radiation oncology is the whether whole-brain radiotherapy should be added to radiosurgery when treating a limited number of brain metastases. To optimize personalized treatment of cancer patients with brain metastases, the value of whole-brain radiotherapy should be described separately for each tumor entity. This study investigated the role of whole...

2016
Bob T. Li Emil Lou Meier Hsu Helena A. Yu Jarushka Naidoo Marjorie G. Zauderer Camelia Sima Melissa L. Johnson Mariza Daras Lisa M. DeAngelis Martin Fleisher Mark G. Kris Christopher G. Azzoli Amit Dutt

BACKGROUND Lung cancers account for the majority of brain metastases which pose major therapeutic challenges. Biomarkers prognosticating for the development of brain metastases in patients with non-small cell lung cancers (NSCLC) may improve personalized care. Six serum proteomic biomarkers were previously investigated at Memorial Sloan Kettering but their associations with brain metastases wer...

2015
Zhenye Li Xiangheng Zhang Xiaobing Jiang Chengcheng Guo Ke Sai Qunying Yang Zhenqiang He Yang Wang Zhongping Chen Wei Li Yonggao Mou

PURPOSE Brain metastasis is the most common complication of brain cancer; nevertheless, primary lung cancer accounts for approximately 20%-40% of brain metastases cases. Surgical resection is the preferred treatment for brain metastases. However, no studies have reported the outcome of surgical resection of brain metastases from non-small-cell lung cancer (NSCLC) in the People's Republic of Chi...

2013
Heike Niessner Andrea Forschner Bernhard Klumpp Jürgen B. Honegger Maria Witte Antje Bornemann Reinhard Dummer Annemarie Adam Jürgen Bauer Ghazaleh Tabatabai Keith Flaherty Tobias Sinnberg Daniela Beck Ulrike Leiter Cornelia Mauch Alexander Roesch Benjamin Weide Thomas Eigentler Dirk Schadendorf Claus Garbe Dagmar Kulms Leticia Quintanilla-Martinez Friedegund Meier

Brain metastases are the most common cause of death in patients with metastatic melanoma, and the RAF-MEK-ERK and PI3K-AKT signaling pathways are key players in melanoma progression and drug resistance. The BRAF inhibitor vemurafenib significantly improved overall survival. However, brain metastases still limit the effectiveness of this therapy. In a series of patients, we observed that treatme...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Menghong Sun Carmen Behrens Lei Feng Natalie Ozburn Ximing Tang Guosheng Yin Ritsuko Komaki Marileila Varella-Garcia Waun Ki Hong Kenneth D Aldape Ignacio I Wistuba

PURPOSE To compare the characteristics of deregulation of HER receptors and their ligands between primary tumor and corresponding brain metastases of non-small cell lung carcinoma (NSCLC). EXPERIMENTAL DESIGN Fifty-five NSCLC primary tumors and corresponding brain metastases specimens were examined for the immunohistochemical expression of epidermal growth factor receptor (EGFR), phosphorylat...

Journal: :Current treatment options in oncology 2000
P Y Wen J S Loeffler

Brain metastases are an increasingly common complication in patients with systemic cancer. The optimal treatment for each patient depends on careful evaluation of several factors: the location, size, and number of brain metastases; the patient's age, general condition, and neurologic status; and the extent of systemic cancer to name a few. For patients with a single brain metastasis and limited...

Journal: :Neuro-oncology 2022

Abstract Brain metastases are frequently seen in neurosurgical practice. Standardised criteria created to better classify these common pathologies research studies. This study’s goal was evaluate RANO-BM (Response Assessment Neuro-Oncology - Metastases) criteria’s current thresholds a cohort of patients with brain managed by stereotactic radiosurgery (SRS). We performed retrospective metastasis...

2009
Peter J. Mazzone Nicola Marchi Vince Fazio J. Michael Taylor Thomas Masaryk Luke Bury Tarek Mekhail Damir Janigro

BACKGROUND Brain metastases occur commonly in patients with lung cancer. Small vessel ischemic disease is frequently found when imaging the brain to detect metastases. We aimed to determine if the presence of small vessel ischemic disease (SVID) of the brain is protective against the development of brain metastases in lung cancer patients. METHODOLOGY/PRINCIPAL FINDINGS A retrospective cohort...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید